Avant BrandsFRA:1BU +3.59%38 Gross Margin % is 50.72% as of Feb. 2026, which is 51% above its 10-year median of 33.59. GuruFocus rates FRA:1BU with a GF Score™ of 38/100 and a GF Value™ of €0.70 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 935 Drug Manufacturers companies, Avant Brands ranks worse than 87.7% on this metric.
The historical rank and industry rank for Avant Brands's Gross Margin % or its related term are showing as below:
FRA:1BU'
s Gross Margin % Range Over the Past 10 Years
Min: -4.68 Med: 33.59 Max: 303.45
Current: 24.51
During the past 13 years, the highestGross Margin % of Avant Brands was 303.45%. The lowest was -4.68%. And the median was 33.59%.
FRA:1BU's Gross Margin % is ranked worse than 87.7% of 935
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs FRA:1BU: 24.51
Avant Brands had a gross margin of 50.72% for the quarter that ended in Feb. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Avant Brands was 0.00% per year.
Avant Brands (FRA:1BU) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Avant Brands had a gross margin of 50.72% for the quarter that ended in Feb. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Avant Brands Gross Margin % Related Terms
Avant Brands Gross Margin % Historical Data
* Premium members only.
The historical data trend for Avant Brands's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Avant Brands's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avant Brands Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Avant Brands's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Avant Brands's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Avant Brands (FRA:1BU) has a Gross Margin % of 50.72% as of Feb. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Avant Brands and its competitors. This is 51% above median its historical median of 33.59. According to the industry distribution chart, Avant Brands ranks #820 out of 935 companies in the Drug Manufacturers industry, placing it in the top 87.7%.
Is Avant Brands' Gross Margin % too high?
Avant Brands' current Gross Margin % of 50.72% is 51% above median its 10-year median of 33.59. The Drug Manufacturers industry median Gross Margin % is 48.54. Avant Brands' value of 50.72% is 4.5% above this industry median. Based on the distribution chart, Avant Brands ranks #820 out of 935 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Avant Brands has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avant Brands' Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Avant Brands ranks #820 out of 935 companies for Gross Margin %. This places Avant Brands in the lower half of its industry. The industry median Gross Margin % is 48.54. Avant Brands' value of 50.72% is 4.5% above this benchmark. While the company's 10-year median is 33.59 vs. the industry median of 48.54, Avant Brands has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avant Brands's current Gross Margin % of 50.72% is 4.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Avant Brands and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avant Brands's current Gross Margin % is 50.72%, which is 51% above median its own 10-year median of 33.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avant Brands stock overvalued right now?
Based on GuruFocus' analysis, Avant Brands (FRA:1BU) is currently considered Possible Value Trap. The stock's GF Value™ is €0.70, compared to a current price of €0.35 — trading 50.6% below its estimated fair value. The current Gross Margin % is 50.72%, which is 51% above median its 10-year median of 33.59 and 4.5% above the Drug Manufacturers industry median of 48.54. Avant Brands' overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Avant Brands (FRA:1BU), the current Gross Margin % is 50.72% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avant Brands (FRA:1BU) Overvalued in 2026?
Based on GuruFocus' analysis, Avant Brands stock appears to be undervalued.
The current stock price of €0.35 is trading 50.6% below its estimated GF Value™ of €0.70.
GuruFocus considers Avant Brands to be Possible Value Trap.
Key valuation signals for FRA:1BU:
Gross Margin %: 50.72% (51% above median its 10-year median of 33.59)
GF Value™: €0.70 vs. price of €0.35 (50.6% below fair value)
Industry Position: 4.5% above the Drug Manufacturers median (#820 of 935)
No single metric tells the full story. See the FRA:1BU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avant Brands Inc operating in the cannabis industry, engages in the cultivation, production, marketing, and sale of cannabis products. Its product portfolio mainly consists of dried cannabis flower and related cannabis products, with the company managing the entire value chain from cultivation and harvesting to processing, packaging, and distribution, generating revenue upon delivery of products to customers. It operates in Canada.
38GF Score
Get the complete analysis for FRA:1BU
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1BU has been successfully added to your 
